Literature DB >> 15348356

A study of the cellular response to orientated fibronectin material in healing extensor rat tendon.

F Zavahir1, D A McGrouther, A Misra, K Smith, R A Brown, V Mudera.   

Abstract

3D orientated fibronectin (Fn) mats have been used as biocompatible and biodegradeable scaffolds to provide orientated cues using contact guidance for cell migration/adhesion and deposition of extracellular matrix. We have implanted Fn scaffolds in an established rat tendon(partial tenotomy) injury model to test its efficacy and monitor the early cellular and inflammatory response. Tendons were harvested at 0, 6 h, 1, 3, 5, 7 and 14 days for H&E, immunohistochemistry and TEM. Total cell counts within the window increased progressively with time with no significant differences between the Fn scaffolds and controls. CD45 (pan leukocyte) positive cell numbers peaked at 6 h and when expressed as a percentage of total cell counts as determined by H&E staining constituted 20% of the total cell number at 6 h but decreased to 5% of total number by 72 h. There were no significant differences in the inflammatory response between the control and implanted groups. Few CD44 (mesenchymal stem cell) positive cells identified had a surface location. A novel cell with long exaggerated cytoplasmic processes was identified by TEM. Our results show that the Fn scaffold did not degrade or elicit any untoward inflammatory response at the time points tested and has potential use in guiding the repair process. Copyright 2001 Kluwer Academic Publishers

Entities:  

Year:  2001        PMID: 15348356     DOI: 10.1023/a:1012877504092

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  19 in total

Review 1.  A new look at the origin, function, and "stem-cell" status of muscle satellite cells.

Authors:  P Seale; M A Rudnicki
Journal:  Dev Biol       Date:  2000-02-15       Impact factor: 3.582

Review 2.  Matrix metabolism and healing in the flexor tendon. Experimental studies on rabbit tendon.

Authors:  S O Abrahamsson
Journal:  Scand J Plast Reconstr Surg Hand Surg Suppl       Date:  1991

3.  The early stages of flexor tendon healing: a morphologic study of the first fourteen days.

Authors:  R H Gelberman; J S Vandeberg; P R Manske; W H Akeson
Journal:  J Hand Surg Am       Date:  1985-11       Impact factor: 2.230

4.  Orientated mats of fibronectin as a conduit material for use in peripheral nerve repair.

Authors:  I H Whitworth; R A Brown; C Doré; C J Green; G Terenghi
Journal:  J Hand Surg Br       Date:  1995-08

5.  Differential cellular response within the rabbit tendon unit following tendon injury.

Authors:  S Kakar; U Khan; D A McGrouther
Journal:  J Hand Surg Br       Date:  1998-10

Review 6.  Tissue engineering.

Authors:  R Langer; J P Vacanti
Journal:  Science       Date:  1993-05-14       Impact factor: 47.728

7.  Adhesion, orientation, and movement of cells cultured on ultrathin fibronectin fibers.

Authors:  B Wòjciak-Stothard; M Denyer; M Mishra; R A Brown
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-02       Impact factor: 2.416

8.  Preparation of orientated fibrous mats from fibronectin: composition and stability.

Authors:  R A Brown; G W Blunn; O S Ejim
Journal:  Biomaterials       Date:  1994-05       Impact factor: 12.479

9.  Fibronectin in healing flexor tendons subjected to immobilization or early controlled passive motion.

Authors:  D Amiel; R Gelberman; F Harwood; D Siegel
Journal:  Matrix       Date:  1991-06

10.  Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo.

Authors:  C R Bjornson; R L Rietze; B A Reynolds; M C Magli; A L Vescovi
Journal:  Science       Date:  1999-01-22       Impact factor: 47.728

View more
  1 in total

1.  The cellular biology of flexor tendon adhesion formation: an old problem in a new paradigm.

Authors:  Jason K F Wong; Yin H Lui; Zoher Kapacee; Karl E Kadler; Mark W J Ferguson; Duncan A McGrouther
Journal:  Am J Pathol       Date:  2009-10-15       Impact factor: 4.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.